This metabolite features a PDE selectivity profile much like sildenafil and an in vitro potency for PDE5 somewhere around fifty% with the mother or father drug. Plasma concentrations of this metabolite are about 40% of People viewed for sildenafil, so which the metabolite accounts for approximately twenty% of sildenafil’s pharmacologic results.Si